Cargando…
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis
The aim of this study was the identification of specific proteomic profiles, related to a restored cystic fibrosis transmembrane conductance regulator (CFTR) activity in cystic fibrosis (CF) leukocytes before and after ex vivo treatment with the potentiator VX770. We used leukocytes, isolated from C...
Autores principales: | Pedrazzi, Marco, Vercellone, Silvia, Barberis, Elettra, Capraro, Michela, De Tullio, Roberta, Cresta, Federico, Casciaro, Rosaria, Castellani, Carlo, Patrone, Mauro, Marengo, Emilio, Lecca, Paola, Melotti, Paola, Sorio, Claudio, Manfredi, Marcello, Averna, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068931/ https://www.ncbi.nlm.nih.gov/pubmed/33920274 http://dx.doi.org/10.3390/ijms22083928 |
Ejemplares similares
-
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators
por: Capraro, Michela, et al.
Publicado: (2023) -
Revisiting the Role of Leukocytes in Cystic Fibrosis
por: Averna, Monica, et al.
Publicado: (2021) -
Calpain Inhibition Promotes the Rescue of F(508)del-CFTR in PBMC from Cystic Fibrosis Patients
por: Averna, Monica, et al.
Publicado: (2013) -
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020) -
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis
por: Conti, Jessica, et al.
Publicado: (2022)